The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study

References

• Bachmann GA, Nevadunsky NS. 2000. Diagnosis and treatment of atrophic vaginitis. American Family Physician 61:3090–3096.
   PubMed Web of Science ®Google Scholar
• Bride MBM, Rhodes DJ, Shuster LT. 2010. Vulvovaginal atrophy. Mayo Clinic Proceedings 85:87–94.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. 2002. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. Journal of Sex and Marital Therapy 28:317–330.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J. 2015. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. Journal of Women’s Health 24:713–722.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. 1990. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands) 16:199–208.
   PubMed Web of Science ®Google Scholar
• Gass MLS, Cochrane BB, Larson JC, Manson JE, Barnabei VM, Brzyski RG, et al. 2011. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women’s Health Initiative. Menopause (New York, N.Y.) 18:1160–1171.
   PubMed Web of Science ®Google Scholar
• Goldstein I, Alexander JL. 2005. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. The Journal of Sexual Medicine 2:154–165.
   PubMed Web of Science ®Google Scholar
• Huang AJ, Gregorich SE, Kuppermann M, Nakagawa S, Van Den Eeden SK, Brown JS, et al. 2015. Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause (New York, N.Y.) 22:144–154.
   PubMed Web of Science ®Google Scholar
• Hunter MM, Nakagawa S, Van Den Eeden SK, Kuppermann M, Huang AJ. 2016. Predictors of impact of vaginal symptoms in postmenopausal women. Menopause (New York, N.Y.) 23:40–46.
   PubMed Web of Science ®Google Scholar
• Kao A, Binik YM, Amsel R, Funaro D, Leroux N, Khalifé S. 2012. Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. The Journal of Sexual Medicine 9:2066–2076.
   PubMed Web of Science ®Google Scholar
• Kelley C. 2007. Estrogen and its effect on vaginal atrophy in post-menopausal women. Urologic Nursing 27:40–45.
   PubMedGoogle Scholar
• Kingsberg SA, Wysocki S, Magnus L, Krychman ML. 2013. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. The Journal of Sexual Medicine 10:1790–1799.
   PubMed Web of Science ®Google Scholar
• Levine KB, Williams RE, Hartmann KE. 2008. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause (New York, N.Y.) 15:661–666.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. 2010. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 67:233–238.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. 2012. Vaginal Health: Insights, Views and Attitudes (VIVA) – results from an international survey. Climacteric: The Journal of the International Menopause Society 15:36–44.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Nijland EA. 2008. Women's perception of sexuality around the menopause: outcomes of a European telephone survey. European Journal of Obstetrics, Gynecology, and Reproductive Biology 137:10–16.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. 2014. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric: The Journal of the International Menopause Society 17:3–9.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Biglia N, Cagnacci A, Di Carlo C, Luisi S, Paoletti AM. 2016. Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 32:602–606.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Mattsson L-Å, Lachowsky M, Maamari R, Giraldi A. 2013. The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe. Maturitas 75:373–379.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Bruyniks N, Particco M, Panay N; EVES Study Investigators. 2019. The burden of vulvovaginal atrophy on women’s daily living: implications on quality of life from a face-to-face real-life survey. Menopause (New York, N.Y.) 26:485–491.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, Particco M, Krychman ML. 2016. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 19:188.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Particco M, Biglia N, Cagnacci A, Di Carlo C, Luisi S, et al. 2016. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: evidence from the European REVIVE survey. Maturitas 91:74–80.
   PubMed Web of Science ®Google Scholar
• Palacios S, Nappi RE, Bruyniks N, Particco M, Panay N; EVES Study Investigators. 2018. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric: The Journal of the International Menopause Society 21:286–291.
   PubMed Web of Science ®Google Scholar
• Palma F, Volpe A, Villa P, Cagnacci A; writing group of the AGATA study. 2016. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 83:40–44.
   PubMed Web of Science ®Google Scholar
• Portman D, Palacios S, Nappi RE, Mueck AO. 2014. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas 78:91–98.
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N; International Menopause Society Writing Group. 2010. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric: The Journal of the International Menopause Society 13:509–522.
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. 2005. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. Journal of Sex and Marital Therapy 31:1–20.
   PubMed Web of Science ®Google Scholar
• Wysocki S, Kingsberg S, Krychman M. 2014. Management of vaginal atrophy: implications from the REVIVE survey. Clinical Medicine Insights. Reproductive Health 8:23–30.
   PubMedGoogle Scholar